Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

Study sheds new light on asbestos-related cancer

US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail.

Dampening the immune system improves response to mesothelioma treatment

Suppressing the body's natural defences could improve how well mesothelioma patients respond to certain treatments, a US study suggests.

DIYers urged to be asbestos aware

A new survey has highlighted the need for Britons to improve their awareness of asbestos.

Asbestos cancer toll will not peak until 2015

Almost 200,000 people in the UK could still get asbestos-related cancers from exposure in the 60s and 70s, according to experts.

HSE raises asbestos awareness

The Health and Safety Executive (HSE) has launched a new campaign this week to raise awareness of the risks of exposure to asbestos.

NICE approves drug for advanced mesothelioma

The National Institute for Health and Clinical Excellence (NICE) has revised its guidance on Alimta, a drug to treat mesothelioma, an asbestos-related cancer of the lining...

New drug boost for lung cancer sufferers

Clinical trials of a new anticancer drug combination carried out by Cancer Research UK scientists at Newcastle University show that it has the potential to almost double...